Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Point-Of-Care-Testing (POCT) Market Size Forecast: How Big Could The Market Get By 2030?#_x000D_
The point-of-care-testing (poct) market size has experienced significant growth in recent years. It is projected to expand from $50.79 billion in 2025 to $56.68 billion in 2026, at a compound annual growth rate (CAGR) of 11.6%. The market’s historical growth can be attributed to the rising prevalence of chronic diseases, an increasing necessity for rapid clinical decision-making, the expansion of emergency and critical care services, limited access to centralized laboratories, and the demand for immediate diagnostic results._x000D_
_x000D_
The point-of-care-testing (POCT) market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $86.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This growth during the projection period is driven by factors such as progress in POCT device miniaturization, the expansion of home care and remote patient monitoring, an increase in infectious disease outbreaks, greater healthcare decentralization, and the rising uptake of self-testing diagnostics. Key trends expected during the forecast period encompass the increasing integration of rapid diagnostic testing at the point of care, a growing need for home-based and self-testing options, the wider availability of over-the-counter diagnostic products, an intensified focus on early disease detection and screening, and enhancements in the accuracy and sensitivity of POCT devices._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Point-Of-Care-Testing (POCT) Market Growth Factors Behind Sustained Expansion#_x000D_
The expanding use of telemedicine is anticipated to drive the point-of-care-testing (POCT) market’s growth in the future. Telemedicine is defined as the remote provision of medical care, leveraging digital communication methods like video calls, phone calls, or secure messaging. The uptake of telemedicine stems from an increasing need for convenient, prompt, and contact-free healthcare, especially hastened by the COVID-19 pandemic. Point-of-care testing (POCT) facilitates telemedicine by offering quick, dependable diagnostic outcomes that can be immediately transmitted to distant healthcare professionals. For example, in April 2025, the American Hospital Association, a US-based professional organization, reported that over 12.6% of Medicare beneficiaries used telehealth services in 2023. Projections indicate that the physician count will reach up to 86,000 by 2036. Telehealth is crucial in addressing the growing shortage of physicians. Consequently, the widespread use of telemedicine is propelling the expansion of the point-of-care-testing (POCT) market._x000D_
_x000D_
#Point-Of-Care-Testing (POCT) Market Segment Trends And Revenue Contributors#_x000D_
The point-of-care-testing (poct) market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types_x000D_
2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products_x000D_
3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing _x000D_
4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices_x000D_
2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing_x000D_
3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing_x000D_
4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing_x000D_
5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing_x000D_
6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing_x000D_
7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing_x000D_
8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing_x000D_
_x000D_
#Point-Of-Care-Testing (POCT) Market Industry Trends Fueling Future Revenue Growth#_x000D_
Leading companies in the point-of-care testing (POCT) market are increasingly directing their efforts towards technological innovations, including microfluidic rapid antimicrobial-susceptibility testing (AST) systems. This focus aims to address the rising demand for quicker, clinic-level diagnostics and enhanced antimicrobial stewardship in primary care. This microfluidic AST technology utilizes fluid channels at the micrometer scale to cultivate and identify bacteria from patient samples, such as urine, and determine their antibiotic susceptibility in a significantly reduced timeframe compared to conventional culture-based methods, which often take several days. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, unveiled the PA 100 AST System. This compact POCT analyser incorporates Sysmex Astrego’s proprietary microfluidic cartridges to identify bacteria in approximately 15 minutes and deliver comprehensive AST results in about 30 minutes. The system is highly intuitive: healthcare professionals simply place the sample into a single-use cartridge, insert it into the desktop analyser, and receive automated AST readouts without needing specialized laboratory training. This swift turnaround enables timely antibiotic decisions during the first patient visit, thereby supporting initiatives to lessen inappropriate prescriptions and combat antimicrobial resistance (AMR)._x000D_
_x000D_
#Point-Of-Care-Testing (POCT) Market Competitive Landscape: Which Companies Lead The Industry?#_x000D_
Major companies operating in the point-of-care-testing (poct) market are Johnson & Johnson, F. Hoffmann‑La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, Meridian Bioscience _x000D_
_x000D_
#View The Full Point-Of-Care-Testing (POCT) Market Report:#_x000D_
_x000D_
#Point-Of-Care-Testing (POCT) Market Regional Outlook: Where Is Opportunity Concentrated?#_x000D_
North America was the largest region in the point-of-care testing (POCT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (poct) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.